Healthcare

SINGAPORE (Feb 27): OCBC Investment Research, Phillip Capital and UOB Kay Hian are maintaining their “buy” calls on Raffles Medical Group with a fair value estimate and target prices of $1.26, $1.32 and $1.32 respectively.

SINGAPORE (Feb 14): UOB Kay Hian and Phillip Capital are maintaining their “buy” calls on Health Management International (HMI), both with target prices of 83 cents, after the group’s 1H results for FY2018 came in line with expectations.  

SINGAPORE (Feb 1): Private healthcare provider Health Management International (HMI) has signed a licensing agreement with Gakken Cocofump Holdings to use the latter’s educational content covering best practices in elderly care training.

SINGAPORE (Jan 8): CIMB is maintaining its “hold” call on TalkMed Group with a lower target price of 68 cents from 92 cents previously, after cutting FY17-19F earnings per share (EPS) estimates by 18-21% to factor anticipated earnings losses from the

SINGAPORE (Jan 4): DBS Vickers Securities is reiterating its “buy” on Perennial Real Estate Holdings with a $1.05 price target given the research house is positive on its medium- to long-term development plans.

SINGAPORE (Dec 21): Singapore is embracing technology and focusing more on personal health, as an expected doubling of seniors over the next two decades forces the nation to confront politically sensitive decisions on financing and immigration.

SINGAPORE (Dec 12): Medical technology start-up Advent Access has raised $2.6 million in a pre-Series A financing round led by Accuron MedTech, Southeast Asia’s largest medical device company.

SINGAPORE (Dec 7): As allocations to passive strategies register a decline for the third consecutive year, institutional investors are preparing for volatility, asset bubbles and fragile markets ahead in 2018.

NEW YORK (Dec 4): CVS Health Corp. will buy Aetna Inc. for about US$67.5 billion ($91 billion), creating a health-care giant that will have a hand in everything from insurance to the corner drugstore.

SINGAPORE (Nov 9): DBS Vickers Securities has upgraded its view on Singapore O&G (SOG) to “neutral” from “fully valued” while raising its target price on the healthcare stock to 52 cents from 41 cents previously, which is pegged to 25 times P/E on